Anxiolytics in the treatment of central serous chorioretinopathy
Indian J Ophthalmol
.
2022 Feb;70(2):701.
doi: 10.4103/ijo.IJO_2983_21.
Authors
Ajay I Dudani
1
,
Anadya Dudani
2
,
Krish Dudani
3
,
Anupam Dudani
4
Affiliations
1
Ophthalmologist, Mumbai Retina Centre, Mumbai, Maharashtra, India.
2
Student - K. J. Somaiya Medical College and Hospital, Mumbai, Maharashtra, India.
3
Internship - K. J. Somaiya Medical College and Hospital, Mumbai, Maharashtra, India.
4
Radiologist - P. D. Hinduja Hospital, Mumbai, Maharashtra, India.
PMID:
35086281
PMCID:
PMC9023947
DOI:
10.4103/ijo.IJO_2983_21
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Anxiety Agents* / therapeutic use
Central Serous Chorioretinopathy* / diagnosis
Central Serous Chorioretinopathy* / drug therapy
Choroid Diseases*
Fluorescein Angiography
Humans
Substances
Anti-Anxiety Agents